A multicenter international randomized phase III study comparing cisplatin in combination with irinotecan or etoposide inn previously untreated small-cell lung cancer patients with extensive disease

摘要

Background: This study compared irinotecan plus cisplatin (IP) with etoposide plus cisplatin (EP) in small-cell lung cancer patients with extensive disease.